Japan is once again tightening its stance on cannabis-derived compounds. This time, the focus is on cannabinol (CBN), a cannabinoid less well-known than THC or CBD, but one that is increasingly found in products aimed at relaxation and sleep support. The decision, reported by International CBC, marks a new chapter in the Asian country’s regulation, which has been combining limited medical access with strict punitive policies.
